RFQ 2Week Dose Range & 4Week GLP Toxicity Study in Minipig
As part of the preclinical development plan of the nanoGLA, we require the performance of the toxicological program in second specie, including two main studies: This RFQ is issued to select the most suitable service provider[…]
GAP Analysis CMC and Nonclinical Gap Analysis for NanoGLA
Delbios seeks to subcontract expert services to conduct a CMC and Non-clinical Gap Analysis, providing technical, regulatory, and scientific input to consolidate the nanoGLA development[…]
Method development, validation and bioanalysis for antiGLA antibodies in minipig plasma
In the preclinical development of the nanoGLA it has been a requirement the assessment of anti-drug antibodies production in preclinical species. Currently we request the[…]
Method development, validation and bioanalysis for GLA in minipig plasma
In the preclinical development of the nanoGLA it has been a requirement the assessment of anti-drug antibodies production in preclinical species. We request the development[…]
Method validation for antiGLA in rat plasma
As part of the preclinical development plan, we require the development and validation of a bioanalytical method to perform bioanalysis of toxicological programme supporting a[…]